Chernogolovka, Russia

Sergei O Bachurin


Average Co-Inventor Count = 6.7

ph-index = 3

Forward Citations = 155(Granted Patents)


Company Filing History:


Years Active: 2001-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Sergei O Bachurin

Introduction

Sergei O Bachurin is a notable inventor based in Chernogolovka, Russia. He has made significant contributions to the field of neurodegenerative disorders, holding a total of 3 patents. His work focuses on developing compounds and methods to treat conditions such as Alzheimer's disease.

Latest Patents

Bachurin's latest patents include innovative agents for treating neurodegenerative disorders. One of his key inventions involves compounds and methods that utilize a general formula for treating neurodegenerative diseases. These compounds can be represented by a general formula (I), where Ris can be Me, Et, or PhCH, and other variations. Additionally, he has developed a method for treating neurodegenerative disorders that employs N-acetyl-serotonin (NAS) derivatives for the treatment and prophylaxis of neurological injury and neurodegenerative disorders in mammals.

Career Highlights

Throughout his career, Sergei O Bachurin has worked with several prominent companies, including Selena Pharmaceuticals, Inc. and Medivation, Inc. His expertise in neurobiology and pharmacology has allowed him to make substantial advancements in the treatment of neurodegenerative diseases.

Collaborations

Bachurin has collaborated with notable colleagues such as Nikolai Serafimovich Zefirov and Andrei Z Afanasiev. These partnerships have contributed to the development of his innovative treatments and have enhanced the impact of his research.

Conclusion

Sergei O Bachurin's work in the field of neurodegenerative disorders showcases his dedication to improving treatment options for patients. His patents and collaborations reflect a commitment to advancing medical science and addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…